Olayinka Accepted to Research in Addiction Medicine Scholars (RAMS) Program
Olaniyi Olayinka, MD, MPH, an Addiction Psychiatry fellow in the Yale Department of Psychiatry, has been accepted to the Research in Addiction Medicine Scholars (RAMS) Program 2021-2023 based at Boston University School of Medicine.
Ganesh Receives ECIP Travel Award for 2021 Virtual World Congress of Psychiatric Genetics
Suhas Ganesh, MD, Postdoctoral Associate in the Schizophrenia Neuropharmacology Research Group at Yale (SNRGY), has received an Early Career Investigator Program (ECIP) travel award for the International Society of Psychiatric Genetics’ 2021 Virtual World Congress of Psychiatric Genetics (WCPG).
Crouch Receives F32 Award from NIAAA to Study Alcohol Use Among Alaska Native Populations
Maria Crouch, PhD, Postdoctoral Fellow in the Department of Psychiatry, has been awarded an F32 Postdoctoral Individual National Research Service Award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA).
Doximity Poll: Yale Psychiatry Residency Program Ranks #2 in Research, #3 in Reputation For Second Consecutive Year
For the second consecutive year, the Yale Department of Psychiatry Residency Program has ranked second nationally in research and third in reputation in Doximity’s 2021-22 Residency Navigator program, released July 20.
Ross, Fineberg Awarded Research Grants by Deeda Blair Research Initiative for Disorders of the Brain
David Ross, MD, PhD, Associate Professor of Psychiatry; and Sarah Fineberg, MD, PhD, Assistant Professor of Psychiatry, are among the first three researchers awarded grants through the Deeda Blair Research Initiative for Disorders of the Brain, sponsored by the Foundation for the Institutes of Health (FNIH).
Bonomi, McClurkin Named Recipients of Thomas P. Detre Fellowship Awards
Robin Bonomi, MD, PhD, First-Year Resident, and Michael McClurkin, MD, MPP, Second-Year Resident, have been named recipients of the 2020-21 Thomas P. Detre Fellowship Awards in Translational Neuroscience Research in Psychiatry.
Dwyer, Wilkinson Awarded NIMH Grants to Study Ketamine, Esketamine
The National Institute of Mental Health (NIMH) has awarded grants to two Yale School of Medicine faculty to test the safety, efficacy, and feasibility of ketamine and esketamine or transcranial magnetic stimulation to rapidly reduce suicidal thoughts and behaviors in youth and adults. Jennifer Dwyer, MD, PhD, Assistant Professor in the Yale Child Study Center and Department of Radiology; and Samuel Wilkinson, MD, PhD, Assistant Professor of Psychiatry, are among eight scientists nationally awarded grants by NIMH to study rapid-acting interventions for severe suicide risk.